Home > Insider Trading > Filing (0000899243-21-022993)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1703057	Abcellera Biologics Inc.	ABCL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1834412	G. L. Carl Hansen	C/O Abcellera Biologics Inc. 2215 Yukon Street Vancouver A1 V5Y 0A1	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2021-06-09	5,598,420	$24.03	55,604,330	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-06-09	401,580	$25.50	233,500	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03.
These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the Reporting Person.
On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
These shares are held by Hankla Family Trust (2019), of which the Reporting Person and his spouse are joint trustees. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.